Skip to content

Natera, Inc. NTRA Cash & Equivalents

Cash & Equivalents at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$126M+24.8%
Labcorp Holdings logo
Labcorp HoldingsLH
$981.1M+166%
Quest Diagnostics logo
Quest DiagnosticsDGX
$393M+109%
NeoGenomics logo
NeoGenomicsNEO
$146.14M-57.8%
Illumina logo
IlluminaILMN
$1.09B-2.2%
CareDx logo
CareDxCDNA
$78.47M-12.1%

Other financials

Income statement

See full
Revenue$696.6M+38.8%
Operating income-$93.5M-18.1%
Net income-$85.1M-27.1%
EPS (diluted)-$0.60-20.0%

Balance sheet

See full
Total debt$240.1M+22.7%
Total equity$1.8B+43.1%
Total assets$2.6B+50.9%

Cash flow

See full
Operating cash flow$40.2M-9.6%
CapEx$22.1M+1.5%
Free cash flow$18.0M-20.3%

Valuation

See full
Market cap$38.88B+74.2%
Enterprise value$38.03B+76.7%
P/S15.5×+4.2×

Profitability

See full
Gross margin42.9%
Operating margin-13%+0.6pp
Net margin-14.6%+0.6pp
FCF margin4.2%-0.5pp

Returns & leverage

See full
Return on equity-29%+4.1pp
Debt / equity0.1×0.0×
Current ratio-0.9×

Where this comes from

Reported directly by Natera, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Natera, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Natera, Inc.'s cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Natera, Inc.'s cash & equivalents?
Natera, Inc. (NTRA) reported cash & equivalents of $1.09B in Q1 2026.
How has Natera, Inc.'s cash & equivalents changed year-over-year?
Natera, Inc.'s cash & equivalents increased by 11.7% year-over-year, from $973.77M to $1.09B.
What is the long-term trend for Natera, Inc.'s cash & equivalents?
Over 5 years (2020 to 2025), Natera, Inc.'s cash & equivalents has grown at a 85.6% compound annual growth rate (CAGR), from $48.86M to $1.08B.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.